The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
HemaSphere
(Aug 2023)
P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B-CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB
Mazyar Shadman,
Moshe Y. Levy,
Ryan Porter,
John M. Burke,
Jennifer L. Cultrera,
Jamal Misleh,
Jeff Sharman,
Syed F. Zafar,
Kunthel By,
Aileen Cohen,
Rocco Crescenzo,
Adam Idoine,
Ian W. Flinn
Affiliations
Mazyar Shadman
1 Fred Hutchinson Cancer Research Center, University of Washington, Seattle, United States
Moshe Y. Levy
2 Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, United States
Ryan Porter
3 SSM Health Dean Medical Group, Madison, United States
John M. Burke
4 Rocky Mountain Cancer Centers, Aurora, United States
Jennifer L. Cultrera
5 Florida Cancer Specialists and Research Institute, Leesburg, United States
Jamal Misleh
6 Medical Oncology Hematology Consultants PA, Newark, United States
Jeff Sharman
7 Willamette Valley Cancer Institute and Research Center, Eugene, United States
Syed F. Zafar
8 Florida Cancer Specialists and Research Institute, Fort Myers, United States
Kunthel By
9 BeiGene USA, Inc., San Mateo, United States
Aileen Cohen
9 BeiGene USA, Inc., San Mateo, United States
Rocco Crescenzo
9 BeiGene USA, Inc., San Mateo, United States
Adam Idoine
9 BeiGene USA, Inc., San Mateo, United States
Ian W. Flinn
10 Sarah Cannon Research Institute/Tennessee Oncology, Nashville, United States
DOI
https://doi.org/10.1097/01.HS9.0000969436.70152.b3
Journal volume & issue
Vol. 7
p. e70152b3
Abstract
Read online
No abstracts available.
WeChat QR code
Close